Rosiglitazone attenuates suppression of RXRα-dependent gene expression in inflamed liver
- 31 January 2007
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 46 (1) , 115-123
- https://doi.org/10.1016/j.jhep.2006.09.008
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Retinoid X Receptor α Regulates Glutathione Homeostasis and Xenobiotic Detoxification Processes in Mouse LiverMolecular Pharmacology, 2004
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Effects of Proinflammatory Cytokines on Rat Organic Anion Transporters During Toxic Liver Injury and CholestasisHepatology, 2003
- Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitisJournal of Hepatology, 2003
- Dual Promoter Structure of Mouse and Human Fatty Acid Translocase/CD36 Genes and Unique Transcriptional Activation by Peroxisome Proliferator-activated Receptor α and γ LigandsJournal of Biological Chemistry, 2002
- Endotoxin-stimulated macrophages decrease bile acid uptake in WIF-B cells, a rat hepatoma hybrid cell lineHepatology, 2000
- Immunosuppressant FK506 Activates NF-κB through the Proteasome-mediated Degradation of IκBαPublished by Elsevier ,1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Peroxisome proliferator-activated receptor-γ: a versatile metabolic regulatorAnnals of Medicine, 1999
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995